Field buying-process studies the same week the brief is locked
The pharma-permitted version of patient journey research — verified specialty physicians, AI-moderated voice and video interviews, HIPAA Safe Harbor de-identification, BAA and Sunshine Act-ready data handling. Inside the monthly subscription, fielding starts the week the brief is locked. Incumbent vendors quote 8-12 weeks per study.
Specialists cite efficacy track record as the primary switching trigger; safety profile is the second-order modifier.
Trusted by teams at
Pharma compliance prohibits direct patient journey research that touches PHI. The pharma-permitted alternative is buying-process research — interviews with prescribing physicians on the decision-making process they use when choosing between treatments. Carevoices delivers this within a monthly subscription: verified specialty physicians (oncology, cardiology, GI, neurology, endocrinology) recruited from a 10k+ healthcare panel, AI-moderated voice and video interviews with same-week fielding, BAA on every engagement, HIPAA Safe Harbor de-identification, and Sunshine Act-ready data handling. Brand teams use it for new product validation, switching trigger analysis, competitive positioning research, and KOL decision-driver work — and iterate across multiple rounds inside one subscription cycle rather than waiting 8-12 weeks per incumbent study.
Why Buying-Process Studies Are Hard to Run
Three structural constraints make custom buying-process research a bottleneck on every pharma launch.
Specialty physician recruiting takes 8-12 weeks
Finding 25 GI oncology specialists, 30 cardiologists, or 50 neurologists is the bottleneck. Trackers help; ad-hoc buying-process studies are brutal at incumbent vendor pace. By the time fielding starts, the brand decision window has closed.
Compliance gating adds 30-60 days per engagement
Multi-arm legal review, BAA execution, stimuli pre-approval, identifier stripping documentation. Generic AI research tools fail every check; legacy vendors bolt the compliance package on as a separate workstream that delays fielding.
Brand teams need iteration speed, not one-shot studies
Brand teams want to test, learn, and re-test inside a launch window. 8-12 week incumbent cycles compress the work into one-shot validation — no time for round 2 if the first signal is ambiguous.
Real-world applications
for Buying-Process Studies
Compliance Built In
BAA on every engagement. HIPAA Safe Harbor de-identification by default. US data residency confirmed in writing. Sunshine Act / Open Payments handling — NPI capture + CMS-format export. Stimuli pre-approval workflow with versioning and audit trail.
Faster Insights
Fielding starts the same week the brief is locked. AI-moderated voice and video interviews with verified specialty physicians from a 10k+ healthcare panel. Recruitment takes 7-14 days for mainstream specialties; 14-28 days for rare subspecialties.
Always-On Listening
Monthly subscription with 50 interviews included means the next study fields the moment the prior one closes. Run multiple buying-process rounds, message validation, and KOL deep-dives within the same engagement — no per-project procurement cycle between studies.
How Carevoices buying-process studies compare to common alternatives
| Dimension | Carevoices | Sermo / M3 panel rentals | ZoomRx / typical RFP-driven CRO | Generic AI tools (Outset / Listen Labs) |
|---|---|---|---|---|
| Engagement model | Monthly subscription with 50 interviews included; same-week fielding | Annual panel access subscription + per-survey fees | RFP-driven custom engagement, 30-90 day procurement | Custom RFP-driven engagement design |
| BAA on every engagement | Yes — template available pre-signature | Yes — standard for pharma engagements | Yes — standard for pharma engagements | No published BAA template; 60-120+ day legal retrofit |
| AI-moderated voice/video qualitative | Native — primary delivery mechanism | Survey + community methodology | Hybrid AI + human moderation | Yes — but no healthcare compliance package |
| Stimuli pre-approval workflow for FDA-relevant content | Native — versioning + audit trail per stimulus | Survey-based; not designed for FDA-relevant stimuli testing | Available, layered onto custom engagement | Not built for FDA-relevant content |
| Iteration speed inside a launch window | Multiple rounds within one subscription cycle | Per-study fees on every round | New RFP cycle per round | Custom-scoped per round; no compliance reuse |
From question to intelligence
Decision-question lock
Define the switching question, audience specification, and decision-context stimuli. Recruitment feasibility confirmed before contract signs.
AI-moderated decision-driver interviews
Voice or video interviews with treatment-decision authorities. Laddering uncovers true switching triggers vs. rationalized post-hoc explanations.
Compliant deliverable
De-identified transcripts and verbatim quotes delivered to your analysis stack (Claude Enterprise, MarketSight, internal data science teams).
"We were CROs competing on speed alone, but patient research was the bottleneck — we would quote 8-week timelines while sponsors went to bigger firms in the US and Europe. Carevoices changed the math. We ran 1,203 patient interviews in 48 hours for one sponsor, with HIPAA-grade de-identified transcripts delivered straight into our analysis stack, and the AI moderator went deeper than our human moderators on the first round. Sponsors come to us specifically now because we can do depth research at scale — 34% recruitment uplift, 52% retention. We can now compete globally because of Carevoices."
Stephane Nyombaire, CEO, Nivella Health
How Carevoices Runs Buying-Process Studies
Decision-driver research demands depth — we ladder past surface answers to capture the real switching triggers, alternative consideration sets, and influence chains.
How we recruit
- License + NPI verified clinicians filtered by treatment-decision authority and category experience
- Behavioral fingerprinting across interviews catches AI-assisted respondents that legacy panels miss
- Specialty + practice setting + payer mix segmentation for accurate decision-process modeling
How we deliver
- 5–7 levels of structured laddering uncover the hierarchy of switching triggers, not just the surface answer
- Verbatim transcripts preserve the actual decision language clinicians use — ready for cross-coding
- BAA-covered, HIPAA Safe Harbor de-identified, US data residency in every contract
Field your next buying-process study the week the brief is locked
30-min walkthrough of how the monthly subscription works for buying-process research. Sample compliant deliverable from a recent engagement. Scoping for your specific therapeutic area.
Sample buying-process study deliverable + scoping for your therapeutic area
All-in scope for buying-process and other study types within the monthly subscription
Most engagements clear procurement within 30-60 days at top-20 pharma.
Common questions
Go deeper on Buying-Process Studies
Pillar Guides
Deep-dive guides covering this topic from strategy to execution.
Tools & Tactics
Practical frameworks and platform-specific guides for teams ready to act.
Alternatives & Comparisons
Side-by-side comparisons with competing platforms and approaches.